INTERNATIONAL PATENT: APOGEE THERAPEUTICS, INC. FILES APPLICATION FOR "METHODS OF ADMINISTERING ANTIBODIES THAT BIND INTERLEUKIN 13"

GENEVA, April 20 -- APOGEE THERAPEUTICS, INC. (221 Crescent StreetWaltham, MA 02453) filed a patent application (PCT/US2025/050470) for "METHODS OF ADMINISTERING ANTIBODIES THAT BIND INTERLEUKIN 13" on Oct 10, 2025. With publication no. WO/2026/080829, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HENDERSON, Michael (c/o Apogee Therapeutics, Inc.221 Crescent StreetWaltham, MA 02453), DAMBKOWSKI, Carl Linden (c/o Apogee Therapeutics, Inc.221 Crescent StreetWaltham, MA 02453), WINTER, Erica (c/o Apogee Therapeutics, Inc.2...